Healthcare revenue cycle management provider Medusind has reported a data breach affecting around 361,000 people’s personal and health information. The firm discovered suspicious activity on its network in December 2023 and has since bolstered its security measures. In response to the breach, affected individuals are being offered two years of complimentary identity monitoring services, encouraging them to remain vigilant for any unsanctioned activity on their accounts.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
